BRPI0512288B8 - uso de pelo menos um triterpeno altamente disperso, oleogel contendo triterpeno e processo para a produção de um oleogel contendo triterpeno - Google Patents

uso de pelo menos um triterpeno altamente disperso, oleogel contendo triterpeno e processo para a produção de um oleogel contendo triterpeno

Info

Publication number
BRPI0512288B8
BRPI0512288B8 BRPI0512288A BRPI0512288A BRPI0512288B8 BR PI0512288 B8 BRPI0512288 B8 BR PI0512288B8 BR PI0512288 A BRPI0512288 A BR PI0512288A BR PI0512288 A BRPI0512288 A BR PI0512288A BR PI0512288 B8 BRPI0512288 B8 BR PI0512288B8
Authority
BR
Brazil
Prior art keywords
triterpene
oilgel
producing
weight
highly dispersed
Prior art date
Application number
BRPI0512288A
Other languages
English (en)
Portuguese (pt)
Inventor
Scheffler Armin
Original Assignee
Birken Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34971468&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0512288(B8) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Birken Gmbh filed Critical Birken Gmbh
Publication of BRPI0512288A publication Critical patent/BRPI0512288A/pt
Publication of BRPI0512288B1 publication Critical patent/BRPI0512288B1/pt
Publication of BRPI0512288B8 publication Critical patent/BRPI0512288B8/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C35/00Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C07C35/22Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a condensed ring system
    • C07C35/37Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a condensed ring system with a hydroxy group on a condensed system having three rings
    • C07C35/42Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a condensed ring system with a hydroxy group on a condensed system having three rings derived from the phenanthrene skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J53/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J75/00Processes for the preparation of steroids in general

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Dispersion Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Measuring Volume Flow (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Colloid Chemistry (AREA)
BRPI0512288A 2004-06-22 2005-06-21 uso de pelo menos um triterpeno altamente disperso, oleogel contendo triterpeno e processo para a produção de um oleogel contendo triterpeno BRPI0512288B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102004030044.5 2004-06-22
DE102004030044A DE102004030044A1 (de) 2004-06-22 2004-06-22 Triterpenhaltiger Oleogelbildner, triterpenhaltiges Oleogel und Verfahren zur Herstellung eines triterpenhaltigen Oleogels
PCT/EP2005/006710 WO2005123037A1 (de) 2004-06-22 2005-06-21 Triterpenhaltiger oleogelbildner, triterpenhaltiges oleogel und verfahren zur herstellung eines triterpenhaltigen oleogels

Publications (3)

Publication Number Publication Date
BRPI0512288A BRPI0512288A (pt) 2008-03-25
BRPI0512288B1 BRPI0512288B1 (pt) 2019-05-21
BRPI0512288B8 true BRPI0512288B8 (pt) 2021-05-25

Family

ID=34971468

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0512288A BRPI0512288B8 (pt) 2004-06-22 2005-06-21 uso de pelo menos um triterpeno altamente disperso, oleogel contendo triterpeno e processo para a produção de um oleogel contendo triterpeno

Country Status (31)

Country Link
US (2) US8536380B2 (2)
EP (1) EP1758555B2 (2)
JP (1) JP4468987B2 (2)
KR (1) KR101162991B1 (2)
CN (1) CN1972668B (2)
AT (1) ATE423546T1 (2)
AU (1) AU2005253732C1 (2)
BE (1) BE2016C035I2 (2)
BR (1) BRPI0512288B8 (2)
CA (1) CA2571606C (2)
CY (2) CY1109066T1 (2)
DE (2) DE102004030044A1 (2)
DK (1) DK1758555T4 (2)
ES (1) ES2323082T5 (2)
FR (1) FR16C1003I2 (2)
HU (1) HUS1600032I1 (2)
IL (1) IL180057A (2)
LT (1) LTC1758555I2 (2)
LU (1) LU93142I2 (2)
MX (1) MXPA06015233A (2)
NL (1) NL300823I2 (2)
NO (2) NO336747B1 (2)
NZ (1) NZ552280A (2)
PL (1) PL1758555T5 (2)
PT (1) PT1758555E (2)
RS (1) RS50832B2 (2)
RU (1) RU2430717C2 (2)
SI (1) SI1758555T2 (2)
UA (1) UA88308C2 (2)
WO (1) WO2005123037A1 (2)
ZA (1) ZA200610304B (2)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2332525A1 (en) 2009-11-23 2011-06-15 Novaliq GmbH Pharmaceutical composition comprising propofol
DE102009047092A1 (de) * 2009-11-24 2011-05-26 Birken Gmbh Verwendung eines triterpenhaltigen Oleogels zur Wundheilung
ES2537151T3 (es) 2009-12-10 2015-06-02 Neubourg Skin Care Gmbh & Co. Kg Formulaciones de espuma estabilizadas con polímeros, libres de emulsionantes
EP2363108B1 (de) 2010-03-02 2017-08-30 Neubourg Skin Care GmbH & Co. KG Schaumformulierungen enthaltend mindestens ein Triterpenoid
WO2012177825A1 (en) 2011-06-21 2012-12-27 Bvw Holding Ag Medical device comprising boswellic acid
HRP20250066T1 (hr) * 2016-05-12 2025-03-14 Rudjer Boskovic Institute Organski gelatori biljnog ulja niske molekularne težine
JP2019524755A (ja) * 2016-07-18 2019-09-05 アムリット・リサーチ・リミテッド ベツリン含有油中水型泡沫及びその組成物
US20180258277A1 (en) * 2017-03-10 2018-09-13 Kraton Polymers U.S. Llc Fusible oil gel compositions and methods of making and using same
KR102692754B1 (ko) 2017-08-31 2024-08-08 (주)아모레퍼시픽 병풀 추출물 또는 이로부터 유래한 트리테르펜을 고함량으로 포함하는 화장료 조성물 및 이의 제조 방법
EP3973973A1 (en) 2017-10-31 2022-03-30 KaliVir Immunotherapeutics, Inc. Platform oncolytic vector for systemic delivery
MX2020006995A (es) 2018-01-04 2020-09-09 Amryt Res Limited Extractos de corteza de abedul que contienen betulina y su formulacion.
BR112021007877A2 (pt) 2018-10-26 2021-08-03 Viramal Limited composição em gel mucoadesiva
EP3659583B1 (en) 2018-11-30 2023-06-07 Viramal Limited A method of preparing a gelling agent, the gelling agent obtained thereby, and the use of said gelling agent
CN109512780A (zh) * 2019-01-09 2019-03-26 河南省医药科学研究院 一种凝胶药膏及其制备方法和应用
GR1010072B (el) * 2019-05-15 2021-09-15 Αριστοτελειο Πανεπιστημιο Θεσσαλονικης - Ειδικος Λογαριασμος Κονδυλιων Ερευνας Βρωσιμα κτηνιατρικα σκευασματα ενδομαστικης προστασιας θηλαστικων και μεθοδος για την παρασκευη τους
CA3197371A1 (en) 2020-11-19 2022-05-27 Kalivir Immunotherapeutics, Inc. Oncolytic immunotherapy by tumor micro-environment remodeling
EP4329786A4 (en) 2021-04-30 2024-12-11 KaliVir Immunotherapeutics, Inc. Oncolytic viruses for modified mhc expression
DE102024116319B3 (de) 2024-06-11 2025-10-30 Fuchs SE Schmierfett-Zusammensetzungen enthaltend pentacyclische Triterpene als Co-Verdicker, deren Verwendung und Verfahren zu deren Herstellung

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU83173A1 (fr) * 1981-02-27 1981-06-05 Oreal Nouvelles compositions cosmetiques pour le traitement des cheveux et de la peau contenant une poudre resultant de la pulverisation d'au moins une plante et un agent de cohesion
JP3363161B2 (ja) 1991-06-27 2003-01-08 ポーラ化成工業株式会社 非水ゲル化粧料
US5750578A (en) 1997-02-11 1998-05-12 Regents Of The University Of Minnesota Use of betulin and analogs thereof to treat herpesvirus infection
US6403816B1 (en) * 1997-09-30 2002-06-11 Dabur Research Foundation Betulinic acid derivatives having antiangiogenic activity, processes for producing such derivatives and their use for treating tumor associated angiogenesis
FR2779438B1 (fr) * 1998-06-03 2004-12-24 Jean Marc Aiache Gel stable, son procede de preparation, et compositions pharmaceutiques le comprenant
GB9908593D0 (en) * 1999-04-16 1999-06-09 Quest Int Dental compositions containing boswellia extracts
PT1200106E (pt) 1999-07-09 2003-09-30 Bsp Pharma As Composicao contendo extractos de butyrospermum parkii e utilizacao como medicamento ou suplemento dietetico
DE60102402T2 (de) * 2000-02-10 2005-03-10 Loders Croklaan B.V. Fettmischungen mit Kristallmodifikatoren
JP4593864B2 (ja) * 2000-03-28 2010-12-08 ビルケン ゲーエムベーハー 植物抽出物を含有するエマルション、前記エマルションの製造方法並びに植物抽出物の獲得方法
DE10056902A1 (de) * 2000-11-16 2002-05-23 Birken Gmbh Verfahren zur Gewinnung von Triterpenen aus Pflanzen sowie deren Verwendung
AU2001294953A1 (en) * 2000-09-29 2002-04-08 Regents Of The University Of Minnesota Triterpenes having fungicidal activity against yeast
AU2001294959A1 (en) * 2000-09-29 2002-04-08 Robert M. Carlson Triterpenes having antibacterial activity
JP2002138014A (ja) 2000-10-31 2002-05-14 Noevir Co Ltd 微細エマルション組成物
DE10143964A1 (de) * 2001-09-07 2003-03-27 Basf Ag Emulgatorarme oder emulgatorfreie Systeme vom Typ Öl-in-Wasser mit einem Gehalt an Stabilisatoren und einem aminosubstituierten Hydroxybenzophenon
DE10156297A1 (de) * 2001-11-19 2003-05-28 Henkel Kgaa Mittel zum Schutz der Haut
JP2003335627A (ja) 2002-03-14 2003-11-25 Lion Corp 化粧料含浸シート
DE10237281A1 (de) 2002-08-14 2004-03-04 Birken Gmbh Vorrichtung zur kontinuierlichen Extraktion von Extraktstoffen aus Pflanzen
JP3779661B2 (ja) 2002-09-13 2006-05-31 花王株式会社 皮膚化粧料
KR100489701B1 (ko) 2002-10-09 2005-05-16 주식회사 태평양 고농도의 트리터페노이드를 함유하는 미소화 리포좀 및 그제조방법
JP2005004911A (ja) 2003-06-13 2005-01-06 Ikuta Insatsu Kk 磁気カード
DE10329955A1 (de) * 2003-07-03 2005-02-03 Merck Patent Gmbh Verwendung eines hydroalkoholischen Extrakts aus Bauhinia zur Herstellung einer Zubereitung

Also Published As

Publication number Publication date
LU93142I2 (fr) 2016-09-06
NZ552280A (en) 2010-10-29
EP1758555B2 (de) 2011-09-07
RS50832B (sr) 2010-08-31
CY1109066T1 (el) 2014-07-02
JP4468987B2 (ja) 2010-05-26
DE102004030044A1 (de) 2006-01-12
ES2323082T3 (es) 2009-07-06
AU2005253732C1 (en) 2010-01-21
FR16C1003I1 (2) 2016-08-26
SI1758555T1 (sl) 2009-08-31
BE2016C035I2 (2) 2024-10-08
RU2007102084A (ru) 2008-07-27
US20140050790A1 (en) 2014-02-20
CN1972668B (zh) 2013-01-09
NO2016012I1 (no) 2016-07-07
PL1758555T5 (pl) 2011-12-30
LTC1758555I2 (lt) 2017-11-10
BRPI0512288B1 (pt) 2019-05-21
PL1758555T3 (pl) 2009-07-31
NL300823I2 (nl) 2017-06-22
DK1758555T4 (da) 2011-12-19
EP1758555B1 (de) 2009-02-25
JP2008503530A (ja) 2008-02-07
ATE423546T1 (de) 2009-03-15
WO2005123037A1 (de) 2005-12-29
DE502005006701D1 (de) 2009-04-09
SI1758555T2 (sl) 2009-08-31
US8828444B2 (en) 2014-09-09
ES2323082T5 (es) 2012-01-05
IL180057A (en) 2013-11-28
RU2430717C2 (ru) 2011-10-10
US8536380B2 (en) 2013-09-17
NO336747B1 (no) 2015-10-26
KR101162991B1 (ko) 2012-07-10
CY2016025I1 (el) 2016-10-05
KR20070046821A (ko) 2007-05-03
AU2005253732B2 (en) 2009-07-16
PT1758555E (pt) 2009-04-24
IL180057A0 (en) 2007-05-15
ZA200610304B (en) 2007-11-28
UA88308C2 (ru) 2009-10-12
NO2016012I2 (no) 2016-07-07
AU2005253732A1 (en) 2005-12-29
RS50832B2 (sr) 2018-09-28
MXPA06015233A (es) 2007-12-12
CA2571606C (en) 2011-07-19
FR16C1003I2 (fr) 2018-01-19
EP1758555A1 (de) 2007-03-07
CA2571606A1 (en) 2005-12-29
LU93142I9 (2) 2024-11-04
CY2016025I2 (el) 2016-10-05
HUS1600032I1 (hu) 2016-08-29
BRPI0512288A (pt) 2008-03-25
US20070299285A1 (en) 2007-12-27
DK1758555T3 (da) 2009-06-22
NO20070390L (no) 2007-03-16
CN1972668A (zh) 2007-05-30

Similar Documents

Publication Publication Date Title
BRPI0512288B8 (pt) uso de pelo menos um triterpeno altamente disperso, oleogel contendo triterpeno e processo para a produção de um oleogel contendo triterpeno
CL2021000291A1 (es) Constructos de anticuerpos para cldn18.2 y cd3
BR112015021665A2 (pt) misturas de isômeros de (metilciclohe-xil)tolueno, sua produção e uso na fabricação de plastificantes
DE602006006082D1 (de) Plattenstruktur
ES2603070T3 (es) Aglutinante de aluminosilicato activado por álcali que contiene perlas de vidrio
BR112014030020A2 (pt) aparelho para montagem de seções de pá
BR112023018344A2 (pt) Composições de cimento, e métodos das mesmas
AR058753A1 (es) Uso de composiciones nutricionales con fosfolipidos esfingolipidos y colesterol
BRPI0601896A (pt) composições que contêm microgéis e agentes espessantes
AR065368A1 (es) Anticuerpos para moleculas de ige
BRPI0810130A8 (pt) Composição de bebida, processo para produzir uma composição de bebida, e, uso de uma composição de bebida
BR112015023209A8 (pt) novos medicamentos compreendendo uma composição de anticorpo enriquecida com uma carga principal de isoforma
BR112017022878A2 (pt) composição, preparação simbiótica, processo para produzir uma composição, e, uso de uma arabinoxilanase
MX2023009882A (es) Anticuerpos anti-muc1-c y estructuras car-t.
BR112015032339A2 (pt) composição resistente à água
BRPI0401917A (pt) Material em chapa aglutinado com elastÈmero e processo para sua produção
EA200800148A1 (ru) Применение фуллерена с60 в качестве стабилизатора масел
BRPI0517669A (pt) método para gerar uma imagem composta
BRPI0513037A (pt) processo para reduzir a corrosão de metal de um lìquido hidrocarbonáceo, e, mistura hidrocarbonácea
ECSP11011501A (es) 17 -alquil-17 -oxi-estratrienos
ES2329218A1 (es) Neoglicolipidos, sus agregados con nanotubos de carbono, procedimiento de obtencion y aplicaciones
BRPI0805607A2 (pt) suporte para unidades de controle, em especial para unidades de controle de veìculo e feixes de cabo
BR112022027030A2 (pt) Composição, processo e uso
BRPI0606593A2 (pt) mistura de substáncias
JP1779754S (ja) 橋構造体用ユニット

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 21/05/2019, OBSERVADAS AS CONDICOES LEGAIS. (CO) 10 (DEZ) ANOS CONTADOS A PARTIR DE 21/05/2019, OBSERVADAS AS CONDICOES LEGAIS

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 21/06/2005 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF